Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate dosing schedule study in persistent asthma
2006-005228-18Phase 2Completed
- Sponsor
- GSK
- Start
- Oct 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fluticasone in persistent asthma (6 arms), sponsored by GSK. Primary endpoint: Mean change from baseline at Week 8 in trough FEV1. Started Oct 2006; status: completed.
02
Drugs
fluticasone
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2006-005228-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005228-18.